Literature DB >> 1668616

Inhibition of TSH activation of human cultured thyroid cells by tumor necrosis factor: an explanation for decreased thyroid function in systemic illness?

M Poth1, Y C Tseng, L Wartofsky.   

Abstract

Thyroidal economy in systemic nonthyroidal illness (the sick euthyroid syndrome) is marked by reductions in both thyroid function and peripheral T4 to T3 conversion, presumed to reflect a homeostatic mechanism to conserve energy. TSH levels tend to be normal in these patients, and the mechanism underlying reduced thyroidal secretion is unknown. Since increased blood levels of tumor necrosis factor (TNF) are found in many of the conditions associated with the sick euthyroid syndrome, we hypothesized that TNF might affect the function of the thyroid gland. We, therefore, explored the effects of TNF on TSH stimulation of the thyroid, employing a human thyrocyte cell culture model. Cells were incubated with various concentrations (0-1000 pg/mL) of recombinant human TNF-alpha and bTSH (1 mU/mL), with measurement of secreted thyroglobulin (Tg) and cyclic AMP (cAMP) as the end points of stimulation. TNF had no effect on either basal or TSH-stimulated cAMP generation, but significantly blunted TSH-stimulated Tg secretion. No loss of cell viability and growth was observed based on trypan blue exclusion and thymidine incorporation by cells. These studies demonstrated an inhibitory effect on TNF on human thyrocytes in concentrations comparable to blood levels seen in humans during systemic illness. We conclude that increases in serum TNF may be responsible for reduced thyroid function in patients with the sick euthyroid syndrome.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1668616     DOI: 10.1089/thy.1991.1.235

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  8 in total

Review 1.  Euthyroid Sick Syndrome and the role of cytokines.

Authors:  D A Papanicolaou
Journal:  Rev Endocr Metab Disord       Date:  2000-01       Impact factor: 6.514

2.  Thyroid Hormone Status in Sitosterolemia Is Modified by Ezetimibe.

Authors:  Rgia A Othman; Semone B Myrie; David Mymin; Jean-Baptiste Roullet; Andrea E DeBarber; Robert D Steiner; Peter J H Jones
Journal:  J Pediatr       Date:  2017-06-16       Impact factor: 4.406

3.  Relationship of the increased serum interleukin-6 concentration to changes of thyroid function in nonthyroidal illness.

Authors:  L Bartalena; S Brogioni; L Grasso; F Velluzzi; E Martino
Journal:  J Endocrinol Invest       Date:  1994-04       Impact factor: 4.256

4.  Implication from thyroid function decreasing during chemotherapy in breast cancer patients: chemosensitization role of triiodothyronine.

Authors:  Jianbo Huang; Liangbin Jin; Guangyan Ji; Lei Xing; Chaobo Xu; Xiong Xiong; Hongyuan Li; Kainan Wu; Guosheng Ren; Lingquan Kong
Journal:  BMC Cancer       Date:  2013-07-06       Impact factor: 4.430

Review 5.  The cytokine storm and thyroid hormone changes in COVID-19.

Authors:  L Croce; D Gangemi; G Ancona; F Liboà; G Bendotti; L Minelli; L Chiovato
Journal:  J Endocrinol Invest       Date:  2021-02-09       Impact factor: 4.256

6.  Sick Euthyroid Syndrome on Presentation of Patients With COVID-19: A Potential Marker for Disease Severity.

Authors:  Yair Schwarz; Ruth Percik; Bernice Oberman; Dana Yaffe; Eyal Zimlichman; Amir Tirosh
Journal:  Endocr Pract       Date:  2021-01-11       Impact factor: 3.443

7.  Serum levels of thyroid hormones and thyroid stimulating hormone in patients with biliogenic and hyperlipidaemic acute pancreatitis: Difference and value in predicting disease severity.

Authors:  Ning Yang; Dong-Lei Zhang; Jian-Yu Hao; Guang Wang
Journal:  J Int Med Res       Date:  2016-01-25       Impact factor: 1.671

Review 8.  Criminal of Adverse Pregnant Outcomes: A Perspective From Thyroid Hormone Disturbance Caused by SARS-CoV-2.

Authors:  Qiman Shi; Min Wu; Pei Chen; Bo Wei; Hailong Tan; Peng Huang; Shi Chang
Journal:  Front Cell Infect Microbiol       Date:  2022-01-03       Impact factor: 5.293

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.